Thrombocythemia Completed Phase 2 Trials for Pomalidomide (DB08910)

Also known as: Thrombocythaemia / Thrombocytosis / Thrombocytoses

IndicationStatusPhase
DBCOND0020795 (Thrombocythemia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00946270Pomalidomide for Myelofibrosis PatientsTreatment